Peregrine Capital Management LLC Increases Holdings in Avantor, Inc. (NYSE:AVTR)

Peregrine Capital Management LLC boosted its holdings in Avantor, Inc. (NYSE:AVTR - Free Report) by 20.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 857,538 shares of the company's stock after purchasing an additional 147,202 shares during the period. Peregrine Capital Management LLC owned about 0.13% of Avantor worth $18,068,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the business. MassMutual Private Wealth & Trust FSB raised its holdings in shares of Avantor by 99.5% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company's stock worth $26,000 after purchasing an additional 625 shares during the period. Nisa Investment Advisors LLC raised its stake in shares of Avantor by 69.6% in the third quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company's stock valued at $53,000 after buying an additional 835 shares during the period. UMB Bank n.a. lifted its position in shares of Avantor by 56.3% during the 4th quarter. UMB Bank n.a. now owns 2,981 shares of the company's stock valued at $63,000 after buying an additional 1,074 shares during the last quarter. CKW Financial Group grew its stake in shares of Avantor by 116.7% during the 4th quarter. CKW Financial Group now owns 5,200 shares of the company's stock worth $110,000 after acquiring an additional 2,800 shares during the period. Finally, First Horizon Advisors Inc. increased its holdings in Avantor by 30.8% in the 3rd quarter. First Horizon Advisors Inc. now owns 5,629 shares of the company's stock worth $146,000 after acquiring an additional 1,326 shares during the last quarter. 95.08% of the stock is owned by hedge funds and other institutional investors.

Avantor Price Performance

NYSE AVTR traded down $0.16 during trading on Thursday, reaching $17.52. The company's stock had a trading volume of 3,263,606 shares, compared to its average volume of 5,537,204. The firm has a fifty day moving average of $21.16 and a 200 day moving average of $23.05. Avantor, Inc. has a one year low of $17.14 and a one year high of $28.00. The stock has a market capitalization of $11.93 billion, a PE ratio of 16.84, a P/E/G ratio of 1.56 and a beta of 1.28. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.07 and a quick ratio of 0.70.

Avantor (NYSE:AVTR - Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.26 by $0.01. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same period in the previous year, the business earned $0.22 EPS. Analysts expect that Avantor, Inc. will post 1.06 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on AVTR shares. Stifel Nicolaus dropped their price objective on shares of Avantor from $28.00 to $26.00 and set a "buy" rating on the stock in a report on Monday, February 10th. Wells Fargo & Company dropped their price target on shares of Avantor from $28.00 to $25.00 and set an "overweight" rating on the stock in a research note on Monday, February 10th. Barclays reduced their price objective on shares of Avantor from $26.00 to $23.00 and set an "overweight" rating for the company in a research note on Monday, February 10th. Raymond James restated an "outperform" rating and set a $24.00 target price (down previously from $26.00) on shares of Avantor in a research report on Monday, February 10th. Finally, Royal Bank of Canada reduced their price target on Avantor from $33.00 to $31.00 and set an "outperform" rating for the company in a research report on Monday, February 10th. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $25.92.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.